Navigation Links
Unlocking the Immune System's Response to Infection and Injury
Date:6/16/2010

Scientists at The Feinstein Institute for Medical Research, in collaboration with colleagues at the Karolinska Institute, have identified the protein signals at the heart of infection and/or injury, a finding that offers hope for the development of new drugs that selectively block this pathway and prevent sickness syndromes.

Manhasset, NY (Vocus) June 16, 2010 -- It is termed “sickness syndrome,” the clinical response to injury or infection, which includes fever, weight loss, behavioral withdrawal and inflammation. Although it has been known for years that toxins associated with infectious agents can produce this syndrome, until now it has been a mystery as to why patients develop nearly identical clinical signs after sterile injury, absent infection. Scientists at The Feinstein Institute for Medical Research, in collaboration with colleagues at the Karolinska Institute, have identified the protein signals at the heart of this response, a finding that offers hope for the development of new drugs that selectively block this pathway and prevent sickness syndromes.

The study is published in the latest issue of the Proceedings of the National Academy of Sciences.

Feinstein President Kevin J. Tracey, MD, Karolinska’s Ulf Andersson, MD, and colleagues at both institutions have been mining the immune system pathways that play a critical role in the body’s response to infection and trauma. The pathophysiological response that results in sickness syndrome is mediated by cytokines, molecules that ignite an inflammatory immune response. Most of the time it is a measured response to the conditions at hand, but sometimes the system goes awry and sends out too many inflammatory foot soldiers. The results can be disastrous. Understanding how this process works should lead to effective treatments to prevent sepsis and similar conditions.

In the latest study, Dr. Tracey and his colleagues followed the path of an important cytokine called high-mobility group box 1 (HMGB1,) a housekeeping protein that stimulates the release of other cytokines in response to infection or injury. According to the latest study, HMGB1, which is released during both infection and sterile injury, selectively binds and signals through Toll-like receptor 4 (TLR4), an essential component of the immune system that sets in motion the release of other cytokines which produce sickness syndrome. Surprisingly, they also found that the interaction between these two central proteins (HMGB1 and TLR4) requires a single cysteine, because when they substituted this amino acid for another, the signals leading to cytokine release were blocked.

“These results have implications for the rational design and development of experimental therapeutics for use in sterile and infectious inflammation, because the molecular nature of the interaction is localized to a very small region, encompassing a single amino acid,” the authors wrote. Dr. Tracey added: “This is encouraging for future clinical trials, which are needed to block HMGB1 and stop it from interacting with TLR4 in order to prevent sickness syndrome.”

About The Feinstein Institute for Medical Research: Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in Parkinson's disease, Alzheimer’s disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, inflammatory bowel disease, diabetes, human genetics, leukemia, lymphoma, neuroimmunology, and medicinal chemistry. The Feinstein Institute, part of the North Shore-LIJ Health System, ranks in the top 6th percentile of all National Institutes of Health grants awarded to research centers. Feinstein researchers are developing new drugs and drug targets, and producing results where science meets the patient. For more information, please visit www.FeinsteinInstitute.org or http://feinsteininstitute.typepad.com/feinsteinweblog/

Contact: Jamie Talan, science writer-in-residence
516-562-1232
###


Read the full story at http://www.prweb.com/releases/Feinstein_Institute/Infection_Injury/prweb4154434.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Unlocking the Secrets to a Healthier Body
2. Organ Transplant Drug Keeps Immune System in Check
3. Immune memory formation seen in early stages of viral infection
4. Immune Deficiency Foundation Praises ACHDNC Recommendation for SCID Screening in Newborns
5. Immune Response Better With Skin Scratch Vaccination
6. Cancer stem cells suppress immune response against brain tumor
7. DNA Test May Detect Immune Disorder in Infants
8. The Chopra Center for Wellbeing Launches Vedamune: An Ayurvedic Supplement to Support The Immune System
9. Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
10. Immune cell activity linked to worsening COPD
11. Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Unlocking the Immune System's Response to Infection and Injury
(Date:3/27/2017)... ... March 27, 2017 , ... Biotechnology and ... and engagement over the household brands of Top-20 pharma by optimizing clinical trial ... partnering with the right outsourcing payments provider can provide the technology, infrastructure, and ...
(Date:3/27/2017)... ... March 27, 2017 , ... SyncDog, Inc. , the ... partners LG Business Solutions at ATARC Federal Mobile Computing Summit , March ... provide education and examination into the mobility tools and technology employed by the ...
(Date:3/27/2017)... ... March 27, 2017 , ... M&S Technologies, the first ... for the Smart System® 20/20. CE Certification builds upon M&S's long-standing commitment to ... such as ANSI, ISO and proven test methods used in the field of ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... can quickly sideline athletes. A type of groin injury, it occurs when the ... to serious, intense pain in and around the lower torso, as well as ...
(Date:3/27/2017)... NY (PRWEB) , ... March 27, 2017 , ... ... in epigenetic research products enables researchers to pursue the recent RNA methylation “gold ... methylation . In light of the newfound characteristics of N6-methyladenosine, or m6A ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... NEW YORK , March 27, 2017 ... ... that adult use in states where cannabis is legal will generate ... $559 million will be from cannabis specific taxes, such as ... remaining $96 million will be earned from state sales taxes that ...
(Date:3/27/2017)... BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... AGI-134, an immunotherapy for the treatment of multiple cancers, obtained ... featured at the upcoming American Association for Cancer Research ... to be held on April 1-5, 2017. ... An abstract titled ...
(Date:3/27/2017)... Pulmatrix, Inc . (NASDAQ: PULM), a clinical stage biopharmaceutical company ... announced that it has added two experts in the fields ... Scientific Advisory Board . The two experts ... MD, former chief of the Pediatric Pulmonary and Allergy Divisions ... University, and David Denning , MD, ...
Breaking Medicine Technology: